TUMOR-INHIBITING ACTION OF OLIVOMYCIN (16749) AND ANTIBIOTIC 2703 (CHRYSOMALLIN). (EXPERIMENTAL AND CLINICAL OBSERVATIONS).
D000900:Anti-Bacterial Agents; D000970:Antineoplastic Agents; D002277:Carcinoma; D003609:Dactinomycin; D008223:Lymphoma; D009369:Neoplasms / Q000628:therapy*; D009374:Neoplasms, Experimental; D009848:Olivomycins; D010600:Pharmacology; D051381:Rats; D012106:Research; D012509:Sarcoma; D012513:Sarcoma, Experimental
D000900:Anti-Bacterial Agents; D000970:Antineoplastic Agents; D003609:Dactinomycin; D009848:Olivomycins
ACTINOMYCIN; ANTIBIOTICS; ANTINEOPLASTIC AGENTS; CARCINOMA; EXPERIMENTAL LAB STUDY; LYMPHOMA; NEOPLASM THERAPY; NEOPLASMS; NEOPLASMS, EXPERIMENTAL; PHARMACOLOGY; RATS; SARCOMA, EXPERIMENTAL